IFN-gamma is critical for the cure of leishmaniasis in humans and mice
. BALB/c mice are genetically susceptible to infection with the viscer
alizing species of Leshmania, L. chagasi, We have evidence that a solu
ble factor(s) inhibits IFN-gamma production by cultured liver granulom
a cells from BALB/c mice during L, chagasi infection, In contrast, liv
er granulomas from C3H.HeJ mice, which are genetically resistant to L.
chagasi infection, produce abundant IFN-gamma. According to ELISAs an
d neutralization studies, there was not evidence that the Th2-type cyt
okines IL-10 or IL-4 contributed to IFN-gamma suppression. However, bo
th Ab neutralization and immunohistochemistry showed that granuloma-de
rived TGF-beta was, at least in part, responsible for inhibiting IFN-g
amma release by CD4(+) cells in BALB/c liver granuloma cultures, Consi
stently, TGF-beta levels were high in liver granulomas from susceptibl
e BALB/c mice but low in resistant C3H mice or in BALB/c mice that wer
e immunized against L, chagasi disease. Administration of recombinant
adenovirus expressing TGF-beta (AdV-TGF beta) but nut IL-10 (AdV-IL10)
caused genetically resistant C3H mice to become significantly more su
sceptible to L, chagasi infection. In contrast, either AdV-TGF beta or
AdV-IL10 could abrogate the protective immune response achieved by im
munization of BALB/c mice. We conclude that locally secreted TGF-beta
inhibits Th1-associated cure of murine visceral leishmaniasis caused b
y L. chagasi, independently of Th2-type cytokines.